Testosterone treatment for men with chronic heart failure

Heart

Volumn 90, Issue 4, 2004, Pages 446-447

  Pugh, P J ^a   Jones, R D ^b   West, J N ^a   Jones, T H ^b   Channer, K S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SUSTANON 100; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE; FOLLOW UP; HEART FAILURE; HORMONAL THERAPY; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT OUTCOME; WALKING;

EID: 1642463867     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.014639     Document Type: Article

References (5)

1. Pugh PJ, Jones RD, Jones TH, et al. Heart failure as an inflammatory condition: potential role for androgens as immune modulators. Eur J Heart Failure 2002;4:673-80.
2. Pugh PJ, Jones TH, Channer KS. Acute haemodynamic effects of testosterone in men with chronic congestive heart failure. Eur Heart J 2003;24:909-15.
3. Tappler B, Katz M. Pituitary-gonadal dysfunction in low-output cardiac failure. Clin Endocrinol 1979;10:219-26.
4. Singh SJ, Morgan MDL, Scott S, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019-24.
5. Wang C, Alexander G, Berman N, et al. Testosterone replacement therapy improves mood in hypogonadal men - a clinical research centre study. J Clin Endocrinol Metab 1995;81:3578-83.